101 
(F) allows public access to all information 
not in a restricted section; and 
(G) contains any additional information 
the Council determines may be useful in identi-
fying or combating the production, use, or ef-
fects of methamphetamine. 
Thirty days after the website in paragraph (2) is oper-
ational, no funds shall be expended to continue the website 
methresources.gov. 
(c) REVIEW OF POSTED INFORMATION.— 
(1) IN GENERAL.—Not later than 30 days after 
the date of submission of an item by a qualified enti-
ty, the Council shall review an item submitted for 
posting on the website described in subsection 
(b)(2)— 
(A) to evaluate and determine whether the 
item, as submitted or as modified, meets the re-
quirements for posting; and 
(B) in consultation with the Attorney Gen-
eral, to determine whether the item should be 
posted in a restricted section of the website. 
(2) DETERMINATION.—Not later than 45 days 
after the date of submission of an item, the Council 
shall— 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00101
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
102 
(A) post the item on the website described 
in subsection (b)(2); or 
(B) notify the qualified entity that sub-
mitted the item regarding the reason such item 
shall not be posted and modifications, if any, 
that the qualified entity may make to allow the 
item to be posted. 
SEC. 1005. AUTHORIZATION OF APPROPRIATIONS. 
There are authorized to be appropriated— 
(1) for fiscal year 2007— 
(A) $500,000 to establish the NMIC and 
Council; and 
(B) such sums as are necessary for the op-
eration of the NMIC and Council; and 
(2) for each of fiscal years 2008 and 2009, 
such sums as are necessary for the operation of the 
NMIC and Council. 
TITLE XI—MISCELLANEOUS 
PROVISIONS 
SEC. 1101. REPEALS. 
(a) ACT.—Section 710 is repealed. 
(b) FORFEITURE ASSETS.—Section 6073 of the As-
sets Forfeiture Amendments Act of 1988 (21 U.S.C. 
1509) is repealed. 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00102
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
103 
SEC. 1102. CONTROLLED SUBSTANCES ACT AMENDMENTS. 
Section 303(g)(2) of the Controlled Substances Act 
(21 U.S.C. 823(g)(2)) is amended— 
(1) in subparagraph (B)(iii), by striking ‘‘ex-
cept that the’’ and inserting the following: ‘‘unless, 
not sooner than 1 year after the date on which the 
practitioner submitted the initial notification, the 
practitioner submits a second notification to the Sec-
retary of the need and intent of the practitioner to 
treat up to 100 patients. A second notification under 
this clause shall contain the certifications required 
by clauses (i) and (ii) of this subparagraph. The’’; 
and 
(2) in subparagraph (J)— 
(A) in clause (i), by striking ‘‘thereafter’’ 
and all that follows through the period and in-
serting ‘‘thereafter.’’; 
(B) in clause (ii), by striking ‘‘Drug Addic-
tion Treatment Act of 2000’’ and inserting 
‘‘Office of National Drug Control Policy Reau-
thorization Act of 2006’’; and 
(C) in clause (iii), by striking ‘‘this para-
graph should not remain in effect, this para-
graph ceases to be in effect’’ and inserting 
‘‘subparagraph (B)(iii) should be applied by 
limiting the total number of patients a practi-
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00103
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
104 
tioner may treat to 30, then the provisions in 
such subparagraph (B)(iii) permitting more 
than 30 patients shall not apply, effective’’. 
SEC. 1103. REPORT ON LAW ENFORCEMENT INTELLIGENCE 
SHARING. 
Not later than 180 days after the date of enactment 
of this Act, the Director shall submit to Congress a re-
port— 
(1) evaluating existing and planned law enforce-
ment intelligence systems used by Federal, State, 
local, and tribal law enforcement agencies respon-
sible for drug trafficking and drug production en-
forcement; and 
(2) addressing— 
(A) the current law enforcement intel-
ligence systems used by Federal, State, local, 
and tribal law enforcement agencies; 
(B) the compatibility of such systems in 
ensuring access and availability of law enforce-
ment intelligence to Federal, State, local, and 
tribal law enforcement; 
(C) the extent to which Federal, State, 
local, and tribal law enforcement are sharing 
law enforcement intelligence information to as-
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00104
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
105 
sess current threats and design appropriate en-
forcement strategies; and 
(D) the measures needed to ensure and to 
promote effective information sharing among 
law enforcement intelligence systems operated 
by Federal, State, local, and tribal law enforce-
ment agencies responsible for drug trafficking 
and drug production enforcement. 
SEC. 1104. REQUIREMENT FOR SOUTH AMERICAN HEROIN 
STRATEGY. 
(a) IN GENERAL.—Not later than 90 days after the 
date of enactment of this Act, the Director, in coordina-
tion with the Secretary of State, shall submit to Congress 
a comprehensive strategy that addresses the increased 
threat from South American heroin, and in particular Co-
lombian heroin, and the emerging threat from opium 
poppy grown in Peru and often intended for transit to Co-
lumbia for processing into heroin. 
(b) CONTENTS.—The strategy submitted under sub-
section (a) shall include— 
(1) opium eradication efforts to eliminate the 
problem at the source to prevent heroin from enter-
ing the stream of commerce; 
(2) interdiction and precursor chemical con-
trols; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00105
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
106 
(3) demand reduction and treatment; 
(4) alternative development programs, including 
direct assistance to regional governments to demobi-
lize and provide alternative livelihoods to former 
members of insurgent or other groups engaged in 
heroin, cocoa, or other illicit drug production or traf-
ficking; 
(5) efforts to inform and involve local citizens 
in the programs described in paragraphs (1) through 
(4), such as through leaflets advertising rewards for 
information; and 
(6) an assessment of the specific level of fund-
ing and resources necessary to simultaneously ad-
dress the threat from South American heroin and 
the threat from Colombian and Peruvian coca. 
(c) TREATMENT OF CLASSIFIED OR LAW ENFORCE-
MENT SENSITIVE INFORMATION.—Any content of the 
strategy submitted under subsection (a) that involves in-
formation classified under criteria established by an Exec-
utive order, or whose public disclosure, as determined by 
the Director or the head of any relevant Federal agency, 
would be detrimental to the law enforcement of national 
security activities of any Federal, foreign, or international 
agency, shall be presented to Congress separately from the 
rest of the strategy. 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00106
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
107 
SEC. 1105. MODEL ACTS. 
(a) IN GENERAL.—The Director of the Office of Na-
tional Drug Control Policy shall provide for or shall enter 
into an agreement with a non-profit corporation that is 
described in section 501(c)(3) of the Internal Revenue 
Code of 1986 and exempt from tax under section 501(a) 
of such Code to— 
(1) advise States on establishing laws and poli-
cies to address alcohol and other drug issues, based 
on the model State drug laws developed by the 
President’s Commission on Model State Drug Laws 
in 1993; and 
(2) revise such model State drug laws and draft 
supplementary model State laws to take into consid-
eration changes in the alcohol and drug abuse prob-
lems in the State involved. 
(b) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this subsection 
$1,500,000 for each of fiscal years 2007 through 2011. 
SEC. 1106. STUDY ON IATROGENIC ADDICTION ASSOCIATED 
WITH 
PRESCRIPTION 
OPIOID 
ANALGESIC 
DRUGS. 
(a) IN GENERAL.— 
(1) STUDY.—The Director of the Office of Na-
tional Drug Control Policy shall request the Insti-
tute of Medicine of the National Academy of 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00107
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
108 
Sciences to enter into an agreement under which the 
Institute agrees to study certain aspects of iatro-
genic addiction to prescription opioid analgesics in-
cluded in schedules II and III of the Controlled Sub-
stances Act (21 U.S.C. 812). 
(2) IATROGENIC ADDICTION.—In this section, 
the term ‘‘iatrogenic addiction’’ means an addiction 
developed from the use of an opioid analgesic by an 
individual with no previous history of any addiction, 
who has lawfully obtained and used the drug for a 
legitimate medical purpose by administration from, 
or pursuant to the prescription or order of, an indi-
vidual practitioner acting in the usual course of pro-
fessional practice. 
(b) REQUIREMENTS.—The study conducted pursuant 
to this section shall assess the current scientific literature 
to determine, if possible— 
(1) the rate of iatrogenic addiction associated 
with the appropriate use of prescription drugs de-
scribed in subsection (a); 
(2) the impact of iatrogenic addiction associated 
with the appropriate use of prescription drugs de-
scribed in subsection (a) on the individual, the pre-
scriber, other patients, and society in general; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00108
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
109 
(3) the comparative abuse liability of prescrip-
tion drugs described in subsection (a) when used 
properly by the ultimate user for a legitimate med-
ical purpose; and 
(4)(A) what types of prospective or retrospec-
tive studies should be undertaken to determine the 
rate of iatrogenic addiction associated with the ap-
propriate use of the prescription drugs described in 
subsection (a); and 
(B) a feasible timeline for conducting and re-
porting such studies, should the current state of the 
scientific literature be insufficient to determine the 
rate, impact, and comparative abuse liability of pre-
scription drugs described in subsection (a). 
(c) REPORT.—Not later than 1 year after the date 
of enactment of this Act, the Director of the Office of Na-
tional Drug Control Policy shall ensure that the agree-
ment under subsection (a) provides for the submission of 
a report to the Congress on the status of the study con-
ducted pursuant to this section. 
SEC. 1107. REQUIREMENT FOR STRATEGY TO STOP INTER-
NET ADVERTISING OF PRESCRIPTION MEDI-
CINES WITHOUT A PRESCRIPTION. 
Not later than 120 days after the date of the enact-
ment of this Act, the Director of the Office of National 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00109
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
110 
Drug Control Policy shall submit to Congress a strategy 
to stop advertisements that provide information about ob-
taining over the Internet drugs (as defined in section 
702(3) of the Office of National Drug Control Policy Re-
authorization Act of 1998) for which a prescription is re-
quired without the use of such a lawful prescription. 
SEC. 1108. REQUIREMENT FOR STUDY ON DIVERSION AND 
INAPPROPRIATE 
USES 
OF 
PRESCRIPTION 
DRUGS. 
Not later than 90 days after the date of enactment 
of this Act, the Director of the Office of National Drug 
Control Policy, in consultation with the Secretary of 
Health and Human Services, shall submit to Congress a 
report that includes a plan to conduct a study on the ille-
gal diversion and inappropriate uses of prescription drugs, 
including the following: 
(1) Methods to utilize both public use surveys 
that are in existence as of the date of enactment of 
this Act and other surveys to provide appropriate 
baseline data on the natural history of diversion and 
abuse of prescription drugs that are included in 
schedules under the Controlled Substances Act to 
evaluate the extent and nature of potential problems 
with such use to guide corrective actions which may 
reduce such problems without unintentionally hin-
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00110
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
111 
dering access to these drugs for legitimate medical 
purposes. Specifically, other surveys to be considered 
are those that address the abuse of these substances 
on a regional or national basis, and those that ad-
dress the diversion of these substances on a regional 
or national basis. 
(2) A scientifically based analysis of the relative 
contribution of both innate and acquired genetic fac-
tors, environmental factors, psychological factors, 
and drug characteristics that contribute to addiction 
to prescription drugs. 
SEC. 1109. REQUIREMENT FOR AFGHAN HEROIN STRATEGY. 
(a) IN GENERAL.—Not later than 90 days after the 
date of the enactment of this Act, the Director of the Of-
fice of National Drug Control Policy shall submit to the 
Congress a comprehensive strategy that addresses the in-
creased threat from Afghan heroin. 
(b) CONTENTS.—The strategy shall include— 
(1) opium crop eradication efforts to eliminate 
the problem at the source to prevent heroin from en-
tering the stream of commerce; 
(2) destruction or other direct elimination of 
stockpiles of heroin and raw opium, and heroin pro-
duction and storage facilities; 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00111
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
112 
(3) interdiction and precursor chemical con-
trols; 
(4) demand reduction and treatment; 
(5) alternative development programs; 
(6) measures to improve cooperation and co-
ordination between Federal Government agencies, 
and between such agencies, agencies of foreign gov-
ernments, and international organizations with re-
sponsibility for the prevention of heroin production 
in, or trafficking out of, Afghanistan; and 
(7) an assessment of the specific level of fund-
ing and resources necessary significantly to reduce 
the production and trafficking of heroin. 
(c) TREATMENT OF CLASSIFIED OR LAW ENFORCE-
MENT SENSITIVE INFORMATION.—Any content of the 
strategy that involves information classified under criteria 
established by an Executive order, or whose public disclo-
sure, as determined by the Director or the head of any 
relevant Federal agency, would be detrimental to the law 
enforcement or national security activities of any Federal, 
foreign, or international agency, shall be presented to Con-
gress separately from the rest of the strategy. 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00112
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
113 
SEC. 1110. REQUIREMENT FOR SOUTHWEST BORDER COUN-
TERNARCOTICS STRATEGY. 
(a) IN GENERAL.—Not later than 120 days after the 
date of enactment of this Act, and every 2 years there-
after, the Director of National Drug Control Policy shall 
submit to the Congress a Southwest Border Counter-
narcotics Strategy. 
(b) PURPOSES.—The Southwest Border Counter-
narcotics Strategy shall— 
(1) set forth the Government’s strategy for pre-
venting the illegal trafficking of drugs across the 
international border between the United States and 
Mexico, including through ports of entry and be-
tween ports of entry on that border; 
(2) state the specific roles and responsibilities 
of the relevant National Drug Control Program 
agencies (as defined in section 702 of the Office of 
National Drug Control Policy Reauthorization Act of 
1998 (21 U.S.C. 1701)) for implementing that strat-
egy; and 
(3) identify the specific resources required to 
enable the relevant National Drug Control Program 
agencies to implement that strategy. 
(c) SPECIFIC CONTENT RELATED TO DRUG TUN-
NELS BETWEEN THE UNITED STATES AND MEXICO.— 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00113
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
114 
The Southwest Border Counternarcotics Strategy shall in-
clude— 
(1) a strategy to end the construction and use 
of tunnels and subterranean passages that cross the 
international border between the United States and 
Mexico for the purpose of illegal trafficking of drugs 
across such border; and 
(2) recommendations for criminal penalties for 
persons who construct or use such a tunnel or sub-
terranean passage for such a purpose. 
(d) CONSULTATION WITH OTHER AGENCIES.—The 
Director shall issue the Southwest Border Counter-
narcotics Strategy in consultation with the heads of the 
relevant National Drug Control Program agencies. 
(e) LIMITATION.—The Southwest Border Counter-
narcotics Strategy shall not change existing agency au-
thorities or the laws governing interagency relationships, 
but may include recommendations about changes to such 
authorities or laws. 
(f) REPORT TO CONGRESS.—The Director shall pro-
vide a copy of the Southwest Border Counternarcotics 
Strategy to the appropriate congressional committees (as 
defined in section 702 of the Office of National Drug Con-
trol Policy Reauthorization Act of 1998 (21 U.S.C. 
1701)), and to the Committee on Armed Services and the 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00114
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
115 
Committee on Homeland Security of the House of Rep-
resentatives, and the Committee on Homeland Security 
and Governmental Affairs and the Committee on Armed 
Services of the Senate. 
(g) TREATMENT OF CLASSIFIED OR LAW ENFORCE-
MENT SENSITIVE INFORMATION.—Any content of the 
Southwest Border Counternarcotics Strategy that involves 
information classified under criteria established by an Ex-
ecutive order, or whose public disclosure, as determined 
by the Director or the head of any relevant National Drug 
Control Program agency, would be detrimental to the law 
enforcement or national security activities of any Federal, 
State, local, or tribal agency, shall be presented to Con-
gress separately from the rest of the strategy. 
SEC. 1111. REQUIREMENT FOR SCIENTIFIC STUDY OF 
MYCOHERBICIDE IN ILLICIT DRUG CROP 
ERADICATION. 
Not later than 90 days after the date of enactment 
of this Act, the Director of the Office of National Drug 
Control Policy shall submit to the Congress a report that 
includes a plan to conduct, on an expedited basis, a sci-
entific study of the use of mycoherbicide as a means of 
illicit drug crop elimination by an appropriate Government 
scientific research entity, including a complete and thor-
ough scientific peer review. The study shall include an 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00115
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS
116 
evaluation of the likely human health and environmental 
impacts of mycoherbicides derived from fungus naturally 
existing in the soil. 
SEC. 1112. REQUIREMENT FOR STUDY OF STATE PRE-
CURSOR CHEMICAL CONTROL LAWS. 
(a) STUDY.—The Director of National Drug Control 
Policy, in consultation with the National Alliance for 
Model State Drug Laws, shall conduct a study of State 
laws with respect to precursor chemical controls. 
(b) REPORT.—Not later than 6 months after the date 
of the enactment of this Act, the Director of National 
Drug Control Policy shall submit a report to Congress on 
the results of the study under subsection (a), including— 
(1) a comparison of the State laws studied and 
the effectiveness of each such law; and 
(2) a list of best practices observed with respect 
to such laws. 
SEC. 1113. REQUIREMENT FOR STUDY OF DRUG ENDAN-
GERED CHILDREN PROGRAMS. 
(a) STUDY.—The Director of National Drug Control 
Policy shall conduct a study of methamphetamine-related 
activities that are conducted by different Drug Endan-
gered Children programs administered by States. 
(b) REPORT.—Not later than 6 months after the date 
of the enactment of this Act, the Director of National 
VerDate Aug 31 2005 
02:27 Dec 06, 2006
Jkt 059200
PO 00000
Frm 00116
Fmt 6652
Sfmt 6201
E:\BILLS\H6344.IH
H6344
ccoleman on PROD1PC71 with BILLS